Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
Journal of Pediatric Gastroenterology and Nutrition|June 1, 2010
Eosinophilic oesophagitis in infants and children in the region of southern Denmark: a prospective study of prevalence and clinical presentationKasper Dalby, Rasmus G Nielsen, Soren Kruse-Andersen, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 8, 2023
A prospective evaluation of the diagnostic potential of EBV-DNA in plasma and whole bloodLene Ugilt Pagter Ludvigsen, Annemette Sloth Andersen, Stephen Hamilton-Dutoit, et al.
Journal of the National Cancer Institute|February 18, 2011
CYP2D6 inhibition and breast cancer recurrence in a population-based study in DenmarkTimothy L Lash, Deirdre Cronin-Fenton, Thomas P Ahern, et al.
Pharmacoepidemiology and Drug Safety|May 14, 2025
Drug Interactions With Tamoxifen and Treatment Effectiveness in Premenopausal Breast Cancer Patients: A Bayesian Joint Modeling ApproachKirsten M Woolpert, Deirdre P Cronin-Fenton, Per Damkier, et al.
British Journal of Haematology|May 23, 2019
Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapyMette A Pedersen, Lars C Gormsen, Peter Kamper, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2018
Expression of survivin does not appear to influence breast cancer recurrence riskLindsay J Collin, Deirdre P Cronin-Fenton, Thomas P Ahern, et al.
Hormone Research|November 23, 2006
Rapid genetic analysis in congenital hyperinsulinismHenrik B T Christesen, Klaus Brusgaard, Jan Alm, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Pageof 15